Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Presentations

The information set forth in the presentations posted on this page was factually accurate on the date it was issued. While these presentations remain on the Company's website, the Company assumes no duty to update the information to reflect subsequent developments. Consequently, listeners to the presentations should not rely upon the information as current or accurate after their issuance dates.

DateTitleWebcasts
02/13/18
Download DocumentationCharles River Laboratories Q4 2017 Earnings Presentation
Webcast
01/09/18
Download Documentation36th Annual J.P. Morgan Healthcare Conference Presentation
 
Get help downloading or viewing the above file types

Stock Quote

CRL (common)
Price
$109.34
Change (%)
+ 3.71 (3.51%)
Volume
390,653
Exchange
NYSE
Data as of 02/23/18 4:02 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)